Drug combinations; feasibilities and limitations
Ariëns, E.J.
Nederlands Tijdschrift Voor Geneeskunde 117(11): 434-451
1973
ISSN/ISBN: 0028-2162 PMID: 4569839 Document Number: 58173
Document emailed within 1 workday
Related Documents
Horváth, Z. 1973: Studies on the causes for drug abuse using ethylmorphine hydrochloride and acetylsalicylic-acid-containing drug combinations Die Pharmazie 28(4): 242-243Rass, H. 1996: HIV therapy with drug combinations Deutsche Medizinische Wochenschrift 121(25-26): A36
Borsa, M.; Formento, M.L.; Zoni, G. 1973: Determination of nucleosides in drug combinations Bollettino Chimico Farmaceutico 112(10): 707-713
Des Lauriers, A.; Puech, A.; Allilaire, J.F. 1982: Drug combinations in the treatment of depression La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 58(42): 2432-2439
Glogner, P. 1970: Unfavorable and problematic drug combinations. II Der Internist 11(7): 260-261
Jacquillat, C.; Weil, M.; Goguel, A.; Schaison, G.; Delobel, J.; Gemon, M.F.; Brunel-Kotschi, R.; Teillet, F.; Boiron, M.; Bernard, J. 1971: Chemotherapy of Hodgkin's disease with drug combinations La Presse Medicale 79(12): 513-518
Knopp, C.; Korsatko, W. 1982: Determination of oxeladin citrate in drug combinations Die Pharmazie 37(1): 76-77
Soll, D.B.; Weston, J.M. 1979: Ophthalmic fixed-ratio drug combinations American Family Physician 19(4): 156-158
Rustenbeck, I. 2009: Fixed drug combinations--the pros and the cons Medizinische Monatsschrift für Pharmazeuten 32(4): 141-146
Tsoriev, A.E.; Piven', A.I.; Lesniak, O.M. 2001: Feasibilities of MRi imaging in diagnosis of joint diseases Klinicheskaia Meditsina 79(8): 13-17
Shoshkes, M. 1974: The use of propranolol with various drug combinations in the treatment of essential hypertension Journal of the Medical Society of New Jersey 71(8): 581-583
Owsley, H.D.; Rusho, W.J. 1997: Compatibility of common respiratory therapy drug combinations International Journal of Pharmaceutical Compounding 1(2): 121-122
Srimuang, S.; Prariyachatigul, C.; Chaiprasert, A.; Rungsipanuratn, W.; Tanphaichitra, D. 2000: Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp Journal of the Medical Association of Thailand 83(1): 57-60
Shishkov, N.; Drumev, D. 1975: Possible synergic action of some drug combinations against Mycoplasma gallisepticum Veterinarno-Meditsinski Nauki 12(5): 98-105
Tschudi-Steiner, I. 1975: When do drug combinations show the danger of side effects Pharmaceutica Acta Helvetiae 50(11): 415-420
Salvetti, A.; Virdis, A.; Di Venanzio, L. 1993: The rationale for drug combinations in the therapy of arterial hypertension Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 8 Suppl: 107s-110s
Viramontes-Madrid, J.é L.; Jerjes-Sánchez, C.; Pelaez-Ballestas, I.; Aguilar-Chiu, A.; Hernández-Garduño, A.G. 2002: Risk of drug interactions. Combinations of drugs associated with ventricular arrhythmias Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 54(3): 192-197
Kozulitsyna, T.I.; Uvarova, O.A.; Golyshevskaia, V.I.; El'shanskaia, M.P. 1980: Experimental study of therapeutic effect of various antibacterial drug combinations Problemy Tuberkuleza 7: 49-53
Svennevig, J.L.; Wennberg, J.E.; Bernstein, O.; Lange, J. 1975: Cytostatic drug combinations in the treatment of metastatic cancer of the breast Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(32): 1854-1855; 1866
Abdalla, A.; Mazur, N.A.; Shestakova, N.V.; Nazarenko, V.A. 1991: Assessment of the efficacy and safety of class IC antiarrhythmic drug combinations Terapevticheskii Arkhiv 63(1): 56-59